Present is not the same as reachable: a tiny camera watches cancer proteins hide — and get found

Doctors treating breast cancer often ask how much of a protein called PD-L1 a tumour carries, because drugs that block it can free the immune system to attack. A team at Kanazawa University in Japan asked a sharper question: can an antibody actually reach the protein? Using a high-speed atomic force microscope — a probe fine enough to film individual molecules in liquid, in real time — Reon Imakawa, Richard Wong and colleagues watched antibodies meet PD-L1 on tiny packages shed by cancer cells. On packages rich in the protein, more than 80% held antibodies in long, stable embraces; on protein-poor packages, over 90% showed no stable contact at all, and even packages from the same cells differed widely. Vesicles grown from one patient's tumour showed detectable binding on 93.5% of packages. It is early laboratory work, not a test for patients yet — but it suggests future cancer tests may measure not just what is there, but what treatment can touch.

SDG 3 · Good health and well-being — Mechanism: tech innovation